Privia Health Group, Inc. reported significant financial performance for the second quarter of 2025, with revenues reaching $521.2 million, a 23.4% increase from $422.3 million in the same period last year. For the first half of 2025, total revenue was $1.00 billion, up 19.5% from $837.6 million in the first half of 2024. The company's net income attributable to Privia Health Group was $2.7 million for the second quarter, down 22.5% from $3.5 million in the prior year, while net income for the first half increased to $6.9 million from $6.5 million. Operating income for the second quarter was $3.3 million, a decrease of 34.6% compared to $5.1 million in the same quarter of 2024.
The company experienced notable changes in its operational metrics, with provider expenses rising by 25.9% to $406.0 million for the second quarter, driven by increased patient care revenue and a growing number of implemented providers. The cost of platform expenses also increased by 13.7% to $64.9 million, reflecting higher salaries and stock-based compensation. Despite the revenue growth, the increase in operating expenses outpaced revenue growth, leading to a decline in operating income. The company’s cash and cash equivalents decreased to $390.1 million from $491.1 million at the end of 2024, primarily due to cash used in investing activities related to acquisitions.
Strategically, Privia Health expanded its market presence by acquiring a 51% ownership interest in Privia Medical Group Arizona in April 2025, contributing $17.7 million in revenue since the acquisition. The company also entered the Indiana market in late 2024, which has contributed to its growth in implemented providers and attributed lives. As of June 30, 2025, the number of implemented providers increased by 13.8% year-over-year, while attributed lives grew by 15.2%, indicating successful market penetration and provider engagement.
Looking ahead, Privia Health anticipates continued growth driven by its expansion into new markets and the addition of new providers. The company aims to enhance its value-based care offerings and improve patient outcomes, which are expected to further increase its revenue streams. However, management acknowledged potential risks, including regulatory changes and market competition, which could impact future performance. The company remains focused on leveraging its technology-driven platform to achieve operational efficiencies and enhance provider satisfaction, which are critical to sustaining its growth trajectory.
About Privia Health Group, Inc.
Privia Health is a technology-enabled, physician-enablement company that partners with practices, health plans, and health systems to deliver value-based care. Its platform integrates clinical, administrative, and data analytics tools to improve patient outcomes, reduce costs, and enhance provider satisfaction across diverse reimbursement models. Focused on primary care and specialty networks, Privia promotes physician leadership, operational efficiency, and scalable growth in multiple U.S. markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.